134 related articles for article (PubMed ID: 15195138)
1. Gene expression profiling of 1p35-36 genes in neuroblastoma.
Janoueix-Lerosey I; Novikov E; Monteiro M; Gruel N; Schleiermacher G; Loriod B; Nguyen C; Delattre O
Oncogene; 2004 Aug; 23(35):5912-22. PubMed ID: 15195138
[TBL] [Abstract][Full Text] [Related]
2. Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.
McArdle L; McDermott M; Purcell R; Grehan D; O'Meara A; Breatnach F; Catchpoole D; Culhane AC; Jeffery I; Gallagher WM; Stallings RL
Carcinogenesis; 2004 Sep; 25(9):1599-609. PubMed ID: 15090470
[TBL] [Abstract][Full Text] [Related]
3. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
4. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
[TBL] [Abstract][Full Text] [Related]
5. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
[TBL] [Abstract][Full Text] [Related]
6. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
Fransson S; Martinsson T; Ejeskär K
Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
[TBL] [Abstract][Full Text] [Related]
7. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
8. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
[TBL] [Abstract][Full Text] [Related]
9. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
[TBL] [Abstract][Full Text] [Related]
10. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
[TBL] [Abstract][Full Text] [Related]
11. Clinical investigation of neuroblastoma with partial deletion in the short arm of chromosome 1.
Ohtsu K; Hiyama E; Ichikawa T; Matsuura Y; Yokoyama T
Clin Cancer Res; 1997 Jul; 3(7):1221-8. PubMed ID: 9815803
[TBL] [Abstract][Full Text] [Related]
12. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p.
Mukasa A; Ueki K; Matsumoto S; Tsutsumi S; Nishikawa R; Fujimaki T; Asai A; Kirino T; Aburatani H
Oncogene; 2002 Jun; 21(25):3961-8. PubMed ID: 12037678
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of CAMTA1 correlates with adverse outcome in neuroblastoma patients.
Henrich KO; Fischer M; Mertens D; Benner A; Wiedemeyer R; Brors B; Oberthuer A; Berthold F; Wei JS; Khan J; Schwab M; Westermann F
Clin Cancer Res; 2006 Jan; 12(1):131-8. PubMed ID: 16397034
[TBL] [Abstract][Full Text] [Related]
14. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
[TBL] [Abstract][Full Text] [Related]
15. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
Genes Chromosomes Cancer; 2001 Jul; 31(3):228-39. PubMed ID: 11391793
[TBL] [Abstract][Full Text] [Related]
16. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
17. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines.
Mathysen D; Van Roy N; Van Hul W; Laureys G; Ambros P; Speleman F; Wuyts W
Eur J Cancer; 2004 May; 40(8):1255-61. PubMed ID: 15110891
[TBL] [Abstract][Full Text] [Related]
19. Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features.
Christacos NC; Quade BJ; Dal Cin P; Morton CC
Genes Chromosomes Cancer; 2006 Mar; 45(3):304-12. PubMed ID: 16320247
[TBL] [Abstract][Full Text] [Related]
20. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
